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Insulin regulation of the activity and phosphorylation of
branched-chain 2-oxo acid dehydrogenase in adipose tissue
G. Peter FRICK and H. Maurice GOODMAN
Department of Physiology, University of Massachusetts Medical School, Worcester, MA 01655, U.S.A.
The activity of the intramitochondrial branched-chain 2-oxo acid dehydrogenase (BCDH), like that of
pyruvate dehydrogenase, is regulated, at least in part, by interconversion between the active dephosphoryl-
ated enzyme and its inactive phosphorylated form. The stimulatory effect of insulin on BCDH activity was
compared with its effect on phosphorylation of the enzyme. Intact tissues were incubated in the presence or
the absence of insulin, and then mitochondria were isolated and disrupted before assaying for enzyme activity
or estimating the extent of enzyme phosphorylation. Tissues were incubated in either the presence or the
absence of leucine, which also stimulated BCDH activity up to 10-fold. Insulin (1 munit/ml) doubled the
activity ofBCDH in the absence and in the presence of leucine. Together, 1 mM-leucine and insulin appeared
to stimulate BCDH activity fully. Phosphorylation of BCDH was estimated indirectly by measuring the
incorporation of 32p into phosphorylation sites that remained unesterified after preparing mitochondrial
extracts under conditions that preserved the effect of insulin on BCDH activity. Increased incorporation of
32p in these experiments implies decreased phosphorylation in situ when tissues were incubated with insulin
and leucine. In the absence of leucine, little incorporation of 32p into BCDH was detected. In the presence
of leucine, however, incorporation of 32P into BCDH was markedly increased, and insulin increased 32p
incorporation still further. The results support the hypothesis that leucine and insulin both stimulate the
activity of BCDH by promoting its dephosphorylation.
INTRODUCTION
In rat adipose tissue, insulin stimulates two intramito-
chondrial enzyme complexes, PDH [1-5] and BCDH [6].
These complexes oxidize 2-oxo acids derived from glucose
and the branched-chain amino acids, respectively, to
form lipogenic precursors. Both PDH and BCDH are
regulated by product inhibition and also by inter-
conversion between their inactive phosphorylated forms
and their active dephosphorylated forms [7,8]. Insulin
stimulates the activity of PDH by promoting its
dephosphorylation [9,10], but an effect of insulin on the
phosphorylation of BCDH has not been reported. The
activity of BCDH in extracts of insulin-treated tissues
was twice that of controls [6], suggesting that insulin
might also promote its dephosphorylation.
It is not known how the binding of insulin to its
receptor on the cell surface stimulates these enzymes. It
has been suggested that insulin stimulates PDH indirectly
by means of a second messenger that increases the
activity of PDH phosphatase [11,12], but comparable
data for BCDH are not available. Two intramito-
chondrial phosphatases that dephosphorylate PDH
[13,14] and a third phosphatase that dephosphorylates
BCDH [15] have been purified from kidney mitochondria.
However, insulin does not appear to stimulate the activity
of PDH or BCDH in kidney mitochondria (H. M.
Goodman & G. P. Frick, unpublished work), and it is
not known whether any of these phosphatases might
account for the effect of insulin on PDH or BCDH in
adipose-tissue mitochondria.
The regulation of protein kinase and phosphatase
activity can be assessed either by incubating tissues in
buffer containing [32P]Pj and then isolating and analysing
the 32P-labelled phosphoproteins [16], or by isolating
phosphoproteins that have not been radioactively
labelled and determining which phosphorylation sites
contain unlabelled phosphate [17]. We have used an
approach similar to the 'back titration' method of Sale
& Randle [17] to determine whether insulin promotes
dephosphorylation of both PDH and BCDH in adipose
tissue by isolating unlabelled phosphoproteins and
incorporating 32p into those sites that were not already
esterified by unlabelled phosphate. Mitochondrial
proteins were prepared from control and insulin-treated
tissues and incubated with [y-32P]ATP under conditions
that favoured phosphorylation and inactivation ofPDH
and BCDH by endogenous kinases. The availability of
unoccupied phosphorylation sites was estimated from
the amount of 32p that was incorporated into the 32P-
labelled enzymes. The results indicate that insulin
promotes dephosphorylation of both PDH and BCDH.
Studies of BCDH, which appears to be regulated by
protein kinases and phosphatases that differ from the
corresponding enzymes that regulate PDH, may help us
to understand how insulin acts on these intramito-
chondrial enzymes.
METHODS
Male rats weighing 115-130 g were obtained from
Charles River Breeding Laboratories (Wilmington, MA,
U.S.A.) and were maintained on Purina 5008 chow
(Ralston Purina, Richmond, IN, U.S.A.) for approx. 1
week before use. Rats were killed by cervical dislocation,
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and the epididymal fat-pads were immediately excised
and incubated in Krebs-Ringer bicarbonate buffer
(0.12 M-NaCl, 4.7 mM-KCl, 3.6 mM-CaCl2, 1.2 mM-
KH2PO4, 1.2 mM-MgCl2, 25 mM-NaHCO3) that con-
tained 10 mM-fructose and 1 %0 bovine serum albumin
(Fraction V; Reheis Chemical Co., Phoenix, AZ, U.S.A.).
Pooled tissues were incubated in flasks sealed with serum
stoppers and equilibrated with 02/CO2 (19:1). After
incubation for 30 min at 37 °C, some tissues were trans-
ferred to flasks containing fresh buffer plus 1 munit of
insulin/ml, and paired tissues were transferred to buffer
lacking insulin for a second 30 min incubation.
Mitochondria
Mitochondria were isolated essentially as described by
Belsham et al. [18]. The effects of leucine and insulin
on the activity and phosphorylation of BCDH were
preserved by chelation of bivalent cations and rapid
isolation of mitochondria at 0-4 C. When adipose-
tissue mitochondria were isolated in the presence of
100 mM-NaF and 5 mM-4-methyl-2-oxopentanoate to
inhibit phosphatases and BCDH kinase, respectively, the
activity of BCDH was similar to that of mitochondria
isolated in the absence of the inhibitors. Therefore the
inhibitors did not appear to be needed to prevent
activation or inactivation of BCDH during the isolation
procedure, although they do appear to be needed when
assaying BCDH in extracts of liver, kidney and muscle
[19]. In the absence of inhibitors, both the inactive (less
than 10 % of maximal activity) and the active (more than
90 % of maximal activity) forms of BCDH were detected
after isolation of adipose tissue mitochondria without
the inhibitors. Similarly, Denton et al. [20,21] did not
find it necessary to add inhibitors in order to preserve the
effect of insulin on PDH activity in adipose-tissue mito-
chondria.
Approx. 3 g of adipose tissue was homogenized in
30 ml of 10 mM-Hepes, pH 7.4, containing 300 mM-
sucrose, 1 mM-EGTA, 1% bovine serum albumin
(dialysed against 50 mm Tris buffer, pH 7.4, and then
distilled water) and 1 mM-dithiothreitol. In some
experiments a mixture of proteinase inhibitors
(0.1 mM-phenylmethanesulphonyl fluoride, 10 /LM-tosyl-
lysylchloromethane, 10 /sM-tosyl-phenylalanylchloro-
methane, 20 ,ug of leupeptin/ml and 20 #g of pepstatin/
ml; all final concentrations) was added to all of the
buffers in which mitochondria were isolated or
incubated. Tissues were homogenized at 23 °C with an
Ultra-Turrax homogenizer (Tekmar, Cincinatti, OH,
U.S.A.) at approx. 50% full speed for 30 s. The
homogenates were immediately chilled on ice, and
subsequent steps were carried out at 0-4 'C. The
homogenates were centrifuged at 1000 g for 5 min, the
pellets and fat were discarded, and the aqueous portions
were centrifuged at 10000 g for 10 min. The mito-
chondrial pellets were resuspended in 2 ml of buffer
containing a 1:10 dilution of Percoll (Pharmacia,
Piscataway, NJ, U.S.A.) and centrifuged for 3 min at
15000g in 1.5 ml plastic centrifuge tubes. The super-
natants were discarded and the mitochondria were
resuspended in 1 ml of buffer (10 mM-potassium
phosphate, pH 7.4, 150 mM-KCl, 0.1 mM-EGTA and
1 mM-dithiothreitol) and resedimented at 15000g -for
1 min. Before assay of BCDH activity or activation or
inactivation of the enzymes, mitochondria were disrupted
osmotically by resuspending them in a hypo-osmotic
buffer (10 mM-potassium phosphate buffer plus 1 mM-
dithiothreitol) at approx. 0.5 mg of protein/ml.
Both BCDH and PDH were activated by incubating
the disrupted mitochondria for 20 min at 37 °C with
10 mM-MgCl2. The particulate fraction was recovered
by centrifugation at 15000g for 1 min, resuspended
in the hypo-osmotic buffer, and assayed for enzyme
activity. No PDH or BCDH activity was detected in
the supernatant after activating and sedimenting the
enzymes. To estimate the extent of activation, specific
activities were calculated from the initial protein
concentration rather than the protein actually recovered
by sedimenting the particulate fraction. Both enzymes
were inactivated by incubating the disrupted mito-
chondria for 5 min at 37 °C with 0.3 mM-ATP plus 5 /tM-
oligomycin, and the particulate fraction was recovered
by centrifugation and resuspended in the hypo-osmotic
buffer as described above before being assayed for PDH
or BCDH activity.
Assays for BCDH and PDH activity
Samples (100 pll) containing 50-100 ,ug of protein were
assayed for BCDH activity as previously described [6].
The reaction mixture (final volume 150 tl)- contained
10 mM-potassium phosphate buffer, pH 7.4, 3 mM-
MgCl2, 1 mM-EDTA, 1 mM-dithiothreitol, 1 mM-
NAD+, 0.1 mM-CoA, 0.1 mM-thiamin pyrophosphate,
0.1% Triton X-100 and 0.2rmM-4-methyl-2-oxo[1-14C]-
pentanoate (sp. radioactivity 3.5,Ci/,umol). The radio-
active substrate was prepared from [1-14C]leucine
(Amersham, Arlington Heights, IL, U.S.A.) as previously
described [6]. The reactions were terminated after 5 min
by addition of 100 ,ul of 0.3 M-sodium citrate adjusted to
pH 3.0 with H3P04. The reaction vial was placed in a
40 ml plastic tube, which also held a 7 ml scintillation
vial containing several drops of phenethylamine
(Eastman Kodak, Rochester, NY, U.S.A.). The 40 ml
tube was capped and incubated for 30 min at 37 °C to
trap 14CO2, which was measured by liquid-scintillation
spectrometry. The activity of PDH was determined by
the same procedure, except that 5-10,g of protein
was assayed, a solution containing [1-14C]pyruvate
(Amersham) plus unlabelled pyruvate (0.2 mM; 3.5 ,uCi/
,umol) was substituted for 4-methyl-2-oxofl-14C]-
pentanoate, and the reaction was terminated after 2 min.
Incorporation of 32p into mitochondrial proteins
Sites that remained unphosphorylated in the isolated
mitochondria were phosphorylated with [y-32P]ATP by a
procedure similar to that used by Sale & Randle [17]
to study PDH. Mitochondrial proteins (50-100 ,tg)
were phosphorylated in 100 Itl of a solution that con-
tained 5 ,uM-oligomycin, [y-32P]ATP (Amersham) and
unlabelled ATP (0.3 mM, 2 Ci/mmol). After incubation
at 37 °C for 5 min, the mitochondrial proteins were
denatured by addition of 100,l of 1 M-trichloroacetic
acid, sedimented at 10000 g for 1 min, rinsed with 150 ,ul
of 95 % (v/v) ethanol, and redissolved in 150,1u of
60 mM-Tris/HCl buffer, pH 6.8, containing 2 % SDS, 5 %
mercaptoethanol, 10% glycerol and 0.001 % Bromo-
phenol Blue. The amount of protein in samples dissolved
in SDS was determined by the dye-binding assay
described by Schaffner & Weisman [22]. Proteins were
separated bypolyacrylamide-gel electrophoresis on 10 %/ -
acrylamide slab gels. The gels were fixed, stained, and
dried before exposure to X-ray film (Kodak AR-5) to
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detect 32P-labelled proteins. The 32P-labelled bands
located by autoradiography were excised, and the
amount of 32p present in each band was determined by
liquid-scintillation spectrometry. Molecular masses of
32P-labelled proteins were estimated by comparing
their mobilities with those of standards obtained from
Sigma (St. Louis, MO, U.S.A.).
A ratio proportional to the specific radioactivity of
32P-labelled BCDH was calculated from the amount of
32fp recovered in the 50000-Da band and the amount of
protein in the sample that was applied to the gel. After
activation of BCDH by MgC12 this ratio was greatly
increased. Since only 69 + 30% (mean + S.E.M., seven
experiments) of the protein was recovered when the
MgCl2-activated enzyme was sedimented and re-
suspended in fresh buffer, the increased ratio reflects
both enrichment of insoluble mitochondrial proteins for
BCDH and an increase in the specific radioactivity of the
32P-labelled enzyme. When BCDH was activated by
MgCl2, the ratio was corrected for enrichment of the
enzyme and then used to calculate the percentage of
maximum 32p incorporation. The effect of insulin on
32p incorporation into BCDH was determined by
comparing the percentage ofmaximum 32p incorporation
in mitochondria from control and insulin-treated tissues.
To measure the specific radioactivity of [y-32P]ATP,
samples were analysed by h.p.l.c. using a C18 reversed-
phase column as described by Taylor et al. [23]. The
amount of 32P eluted with the ATP peak was determined
by liquid-scintillation spectrometry, and the amount of
ATP was determined by comparing its peak height with
that of a freshly prepared ATP standard (50-500 pmol).
Peak heights were a linear function of the amount of
ATP.
RESULTS AND DISCUSSION
To measure the effects of leucine and insulin on the
activity of BCDH and on its state of phosphorylation,
paired tissue segments were incubated in the absence or
presence of leucine, insulin or both, and then homo-
genized in an iso-osmotic buffer. Mitochondria were
isolated from the homogenates by centrifugation and
resuspended in a hypo-osmotic buffer to disrupt them
before assay for enzyme activity. As reported previously
[6], leucine greatly increased the activity of BCDH, and
the activation persisted throughout the procedure to
isolate and disrupt mitochondria, as shown in Table 1.
When the mitochondrial preparations were incubated in
phosphate buffer containing 10 mM-MgCl2, BCDH
activity increased still further. Stimulation by leucine was
concentration-dependent, and the activity of the leucine-
stimulated enzyme was always less than or equal to that
of the MgCl2-activated enzyme. When tissues were
incubated in 10 mM-leucine the activity of BCDH
appeared to approach its maximum value, as determined
by activation with MgCl2. Since the enzyme appeared to
be maximally stimulated when tissues were incubated in
10 mM-leucine, one would not expect further stimulation
of leucine oxidation by insulin if the stimulatory effect of
insulin were due to activation of BCDH. However, the
rate at which tissue segments oxidized 10 mM-leucine was
increased by more than 30% when insulin was added
[24]. It is possible that the activity of BCDH may not be
the only factor that limits the relatively high rate at
which intact tissues oxidize high concentrations of the
Table 1. Effect of leucine on BCDH activity
Tissues were incubated in the absence or presence of
leucine for 30 min before the isolation and disruption of
mitochondria. One sample of each mitochondrial pre-
paration was incubated for 20 min at 37 °C in the presence
of 10 mM-MgCI2 to maximize BCDH activity. The insol-
uble proteins in both the activated and the untreated
samples were sedimented at 15000 g for 1 min, resuspended
in fresh buffer, and assayed for BCDH activity. Results are
means+S.E.M. for three experiments. After incubation
with Mg2l, the activity of BCDH did not differ in extracts
from tissues that had been incubated at different leucine
concentrations. * Differed significantly from results
obtained without added leucine (P <0.05).
BCDH (nmol/min per mg
of protein)
Leucine Maximum Activity (% of
concn. Activity activity maximum)
(mM) (a) (b) (100 x a/b)
0 0.500+0.062 6.34+0.51 7.97+0.20
0.2 1.12+0.21 5.39+0.18 20.9+4.2
1.0 2.36 + 0.49* 5.74+0.37 41.3 + 8.6*
10 4.60+0.17* 5.56+0.44 83.4+4.4*
Table 2. Effect of insulin on the activity of BCDH in extracts of
tissues incubated in the absence or presence of leucine
Tissue segments were incubated for 30 min in the absence
or presence of leucine, 1 munit of insulin/ml, or both.
Mitochondria were isolated, resuspended in hypo-osmotic
phosphate buffer and assayed for BCDH activity.
Maximum BCDH activity was determined as in Table 1.
Results are means + S.E.M. for the numbers of experiments
indicated in parentheses. The effect of insulin was
calculated from the paired results of the number of
experiments indicated in parentheses, and was significant
at each leucine concentration: *P < 0.05, **P < 0.005.
BCDH activity (nmol/
Leucine min per mg of protein) Increase by
concn. insulin
(mM) Control + Insulin (% of control)
0 (7) 0.235 + 0.057 0.382 + 0.056 81 + 30*
0.2 (6) 0.414+0.058 0.899+0.090 146+49*
1.0 (5) 2.58 +0.34 4.73 +0.47 94+ 27*
Activity (%
of maximum) Increase (% of
maximum
Control + Insulin activity)
0.2 (6) 6.6+ 1.0 14.5+ 1.7 6.16+ 1.03**
1.0 (5) 49.2+6.0 91.8 + 3.7 42.7 + 5.4**
branched-chain amino acids. Other factors, such as the
availability of amino-group acceptors, transport across
the mitochondrial membrane, or product inhibition of
BCDH activity, might influence the rate at which tissues
oxidize 10 mM-leucine and account for some of the
stimulatory effect of insulin.
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When tissues were incubated with insulin, the activity
ofBCDH in mitochondrial extracts doubled, as shown in
Table 2. The 2-fold increase was seen in both the absence
and the presence of 0.2 mm- and 1 mM-leucine, even
though leucine alone stimulated BCDH activity by as
much as 10-fold. These effects on BCDH activity can
account for the nearly 2-fold increase in leucine oxidation
produced by insulin when adipose-tissue segments were
incubated with concentrations of leucine as high as 1 mM
[24]. When tissues were incubated with 1 mM-leucine and
insulin together, the activity of BCDH was 92% of its
maximum value and did not differ significantly from that
of the MgCl2-activated enzyme.
When crude tissue extracts were assayed for BCDH
activity in previous studies [6], we found the stimulatory
effect of insulin only when assays were conducted at
substrate concentrations less than 50 ftM, and suggested
that insulin might lower the Km of the enzyme rather
than increase its V".ax, as would be expected if the effect
of the hormone were to promote the conversion of the
inactive into the active form of BCDH. In the present
study, in which isolated mitochondria were used rather
than crude tissue extracts, the stimulatory effect of insulin
was apparent at a concentration of 200 /M (Table 2). It
is not clear why the stimulatory effect of insulin was not
detected at higher substrate concentrations in the earlier
studies, but the present results obtained with isolated
mitochondria are consistent with the idea that insulin
promotes interconversion of the inactive into the active
form of the enzyme. However, the statistically significant
increase in enzyme activity that was seen when tissues
were incubated in vitro without added leucine (Table 2,
line 1) is of doubtful physiological significance, since the
enzyme was almost entirely inactive even in the presence
of insulin. The results in Tables 1 and 2 illustrate how
insulin and leucine stimulate BCDH activity individually,
and suggest that together they can account for substantial
activation of the adipose-tissue enzyme under physio-
logical conditions.
To inactivate BCDH, isolated mitochondria were
disrupted osmotically and then incubated with 0.3 mM-
ATP plus 5 ,tM-oligomycin to inhibit ATPase activity. At
5 min after addition of ATP, the activities of both PDH
and BCDH were decreased to less than 30% of their
maximum values (Table 3). Greater inactivation could
not be achieved by higher concentrations of ATP or
oligomycin, by longer or shorter incubations, or by
addition of NaF to inhibit phosphatase activity. Re-
activation of the enzymes occurred spontaneously when
the incubations were continued for 30 min, presum-
ably because the enzymes were dephosphorylated after
hydrolysis of the added ATP (results not shown).
The inactivating effect of ATP, though extensive, was
incomplete, and remaining BCDH activity in mito-
chondria isolated from insulin-treated tissues was twice
that of controls (Table 3). Similarly, when mitochondria
were isolated from tissues that were incubated with
leucine, the BCDH activity that remained after treatment
with ATP was higher than that of controls and, as seen
with insulin, was proportional to the activity seen before
the ATP treatment (Fig. 1). Multiple regression analysis
of the BCDH activity that remained after maximal
inactivation with ATP revealed no significant differences
in the efficacy of the ATP treatment in mitochondria
from control, insulin-treated or leucine-treated tissues.
Although the degree of its phosphorylation may deter-
Table 3. Effect of insulin on BCDH and PDH activity after
activation by Mg2" or inactivation by ATP
Tissues were incubated in buffer that contained 0.2 mM-
leucine, in either the presence or the absence of 1 munit of
insulin/ml for 30 min. Mitochondria were isolated and
disrupted before activating BCDH and PDH by incubation
with MgCl2 or inactivating them by incubation with ATP.
Activated, inactivated and untreated samples were
sedimented and resuspended in fresh buffer before assaying
for enzyme activity. Results are means+S.E.M. for the
numbers of experiments in parentheses. Significance of
insulin effects: ap < 0.001 by paired t test, bno significant
difference, cP < 0.005 by paired t test.
Activity (nmol/min per
mg of protein)
Control + Insulin
BCDH (18)
Initial activity 0.761 +0.059 1.44+0.15 a
Maximum activity 7.31 +0.32 7.52+0.34b
Activity after 0.119+0.019 0.224+0.063a
inactivation
Decline in activity 84 84b
(% of initial activity)
PDH (3)
Initial activity 61.5 + 1.1 74.8 + 0.5c
Maximum activity 172 + 5 160 + 8b
Activity after 9.45 + 3.30 6.73 + 1 .42b
inactivation
Decline in activity 85 91b
(% of initial activity)
mine the activity of BCDH, the failure of ATP to
decrease BCDH activity to a value that was independent
of its prior activity suggests that leucine and insulin may
produce persistent changes that regulate the extent to
which BCDH is phosphorylated. The results might reflect
covalent changes in either the kinase or phosphatase that
regulates BCDH activity, or they might reflect the
phosphorylation of a site on BCDH other than that
which regulates its catalytic activity. Two phosphoryl-
ation sites have been identified on BCDH purified from
kidney mitochondria [25], and regulation of enzyme
activity appears to depend on phosphorylation of only
one of them. The function of the second phosphorylation
site is unknown. The two sites have also been identified
in BCDH from adipocytes [16].
Inactivation of PDH by ATP was similar to that of
BCDH. In the three experiments shown in Table 3, we
observed no residual effect of insulin on PDH activity
after addition of ATP, but a small effect might have been
detected with a larger number of observations or with
tissues incubated under different conditions.
In parallel experiments we measured the incorporation
of 32p into BCDH and PDH under the same conditions
as those used to inactivate the enzymes, except that ATP
was made radioactive by the addition of [y-32P]ATP.
Two proteins, with molecular masses of approx. 50 and
46 kDa, were heavily labelled (Fig. 2). The band
corresponding to purified BCDH was not completely
resolved from the much more heavily labelled adjacent
band, which corresponds to PDH [10,26], unless
phosphorylation was carried out in the 'pre-sence of
dichloroacetate, a strong inhibitor ofPDH kinase [26,27].
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Activity before ATP treatment (nmol/min per mg of protein)
ATP on BCDH activity
Mitochondria were isolated from tissues that were incubated with: *, no additions; El 0.2 mM-leucine; *, 0.2 mM-leucine and
I munit of insulin/ml; A, 1.0 mM-leucine; or A, 10 mM-leucine. Enzyme activity was assayed before and after treatment with
0.3 mM-ATP for 5 min. The linear regression has a slope of 0.0981 + 0.0063 and a correlation coefficient of 0.903 (57 observations).
The slope was similar to the mean value of the ratio:
(activity after ATP treatment)/(activity before ATP treatment)
which was 0.1 12 + 0.005 (mean + S.E.M.). No significant difference was seen when the efficacy of the ATP treatment was compared
in mitochondria from control, insulin- or leucine-treated tissues. The effects of leucine and insulin on the activity that remained
after the ATP treatment were also analysed by multiple regression, by using the following model:
y = a+b1x1+b2x2+b3x3
where y = BCDH activity that remained after treatment with ATP, x1 = BCDH activity before treatment with ATP, x2 = leucine
concentration and x3 = insulin concentration. The coefficients estimated by analysing these results, and the probability that the
coefficients differed from zero, were:
Estimate
Coefficient (mean + S.E.M.) P
0.0793 + 0.0122
0.0102 + 0.0057
0.0197+0.0167
0.0233
< 0.001
Not significant
Not significant
We thank Dr. Robert Lew for his assistance with the statistical evaluation of these results.
In agreement with previous reports [26,28,29], dichloro-
acetate also inhibited BCDH kinase, but the effect was
smaller; dichloroacetate decreased the incorporation of
32P into BCDH by less than 2-fold, compared with a
4-fold decrease in 32P incorporation into PDH. A small
amount of 32p was also found in proteins that had
molecular masses less than 46 kDa. Since dichloroacetate
also decreased 32p incorporation into these proteins, it is
possible that they might be proteolytic fragments of
PDH or BCDH, even though proteinase inhibitors did
not appear to diminish their abundance.
Incorporation of 32p into BCDH was increased when
extracts of leucine- and insulin-treated tissues were
compared with controls, and was decreased in the
presence of 4-methyl-2-oxopentanoate. These results are
consistent with the hypothesis that activation of BCDH
by either leucine or insulin corresponds to dephosphoryl-
ation of the enzyme, providing more unoccupied acceptor
sites for 32P. The virtual absence of 32P incorporation
in the presence of 4-methyl-2-oxopentanoate (Fig. 2)
suggests that phosphorylation of these sites was catalysed
by BCDH kinase, which is strongly inhibited by
4-methyl-2-oxopentanoate [26,28,29]. Our results are
consistent with those obtained when incorporation of
32p into BCDH was measured in situ after incubation of
adipocytes in the presence of 4-methyl-2-oxopentanoate
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Table 4. Incorporation of 32P into the 59000 Da subunit of
BCDH in mitochondrial extracts of tissues that were
incubated in the presence or absence of insulin
50 kDa
-46 kDa
Fig. 2. Incorporation of 32P into mitochondrial proteins
Mitochondria (A-E) and purified BCDH (F) were
incubated in the presence of 0.3 mM-[y-32P]ATP (approx.
2 Ci/mmol) and 5 ,uM-oligomycin; 1 mM-dichloroacetate
was also present in B, C, D and E. The mitochondria were
isolated from tissues that were incubated without leucine
(A, B), or with 1 mM-leucine (C-E) and 1 munit of insulin/
ml (D, E). Phosphorylation of BCDH was inhibited by
addition of 1 mM-4-methyl-2-oxopentanoate (E).Purified
BCDH was kindly provided by Dr. S. J. Yeaman (Depart-
ment of Biochemistry, University of Newcastle upon
Tyne). Incubations were terminated by addition of tri-
chloroacetic acid, and 47 ,tg of the radioactive protein in
each sample was separated by SDS/polyacrylamide-gel
electrophoresis and detected by autoradiography.
and [32P]Pi. Under these conditions 32P incorporation was
also inhibited by 4-methyl-2-oxopentanoate [16].
In seven experiments similar to that shown in Fig. 2,
insulin increased the incorporation of 32P from 47 to
780 of that seen when BCDH was activated by
incubation with MgCl2 before addition of [y-32P]ATP
(Table 4). Three estimates of the amount of 32p that
might contaminate 32P-labelled BCDH averaged 29 + 60
of the maximum 32P incorporation into BCDH. These
estimates were obtained by measuring incorporation of
32p into the inactive form of BCDH obtained after
treatment with unlabelled ATP or by isolating mito-
chondria from tissues that were incubated without
added leucine or insulin, and by measuring 32p incor-
poration in the presence of 4-methyl-2-oxopentanoate.
Under these conditions, 32p incorporation represents
phosphorylation of the relatively inactive BCDH, back-
ground 32P, and incorporation into proteins other than
BCDH.
Incubation of tissues with insulin also increased the
subsequent incorporation of 32p into BCDH by
0.49+0.14pmol/mg of protein (mean+S.E.M., 15
observations; P < 0.005) when mitochondria were
isolated from tissues that were incubated with 0.2 mM-
leucine. Although phosphorylation of BCDH was
difficult to measure.under these conditions, because 32p
incorporation was similar to background 32p, the effect
Tissues were incubated for 30 min with 1 mM-leucine in the
presence or absence of insulin, and mitochondria were
isolated, disrupted, and incubated with [y-32P]ATP to
incorporate 32P into BCDH. The 32P-labelled proteins
were separated by SDS/polyacrylamide-gel electro-
phoresis, located by autoradiography, excised and counted
for radioactivity to determine the amount of 32P present.
To estimate the maximum 32P incorporation, mitochondria
were incubated with MgCI2 before incorporation of 32P
into BCDH. Phosphate incorporation into BCDH was
calculated from the 32P incorporation and the specific
radioactivity of [y-32P]ATP. Results are means + S.E.M. for
seven observations: *P < 0.05.
Phosphate incorporation into BCDH
(pmol/mg of protein)
Mitochondrial
extract Control + Insulin Insulin effect
Control (a) 7.84+0.66 12.1 + 1.6 4.26+ 1.42*
Maximally 18.6+3.3 17.6+2.8 -1.03+2.16
activated (b)
Phosphate 47.4+ 5.7 78.0 + 14.9 30.7 + 10.1 *
incorporat-
ion (0 of
maximum)
(100 x a/b)
of insulin was significant and corresponded to stimulation
of enzyme activity by approx. 6% of the maximum
BCDH activity (Table 2). The correspondence between
32p incorporation and the stimulation of BCDH activity
was similar to that in the presence of 1 mM-leucine, since
an increase of 4.26 pmol of phosphate/mg of protein
corresponded to an .increase in BCDH activity equal to
4300 of its maximum activity (Tables 2 and 4). The
incorporation of 32p into BCDH from tissues that were
incubated with 10 mM-leucine was 16 pmol/mg ofprotein
(results not shown), which is similar to that when the
enzyme was activated by MgCl2 before the incorporation
of 32p (Table 4). Incubation of tissues with 10 mM-leucine
and treatment of mitochondria with MgCl2 appeared
to make a similar (maximal) number of potential
phosphorylation sites available for incorporation of 32p
and activated BCDH to a similar degree (Table 1). The
incorporation of 32p into PDH was also increased when
mitochondria from insulin-treated tissues were compared
with those of control tissues, even in the presence of
dichloroacetate (Fig. 2).
When compared with the amount of BCDH activity,
incorporation of 32p into BCDH shown in Table 4
is similar to that seen when the purified enzyme
was phosphorylated [25,28,30]. Approx. 18 pmol of
phosphate/mg of protein was incorporated into proteins
that had a maximum BCDH activity of approx. 6 nmol/
min per mg of protein (Table 1). Therefore 3 pmol of
phosphate was incorporated per munit ofBCDH activity
(1 munit equals 1 nmol of substrate oxidized to 14CO2/
min). For comparison, a maximum of 4.2 pmol of
phosphate/munit of enzyme was incorporated into
BCDH purified from rabbit liver [28], and the maximum
phosphorylation of BCDH purified from bovine or rat
1989
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kidney was 2.2 or 0.7 pmol/munit respectively [25,30].
Although BCDH in adipose tissue appears to differ from
the enzyme in other tissues because it is stimulated by
insulin, the number of potential phosphorylation sites
appears to be similar to that in other tissues.
Insulin and leucine both stimulate the oxidation of
branched-chain amino acids by adipose-tissue segments,
both stimulate the activity of BCDH, and both increase
the availability of phosphorylation sites on the enzyme.
The effect of leucine is likely to depend on its
transamination and is similar to that of 4-methyl-2-
oxopentanoate, which has been shown to inhibit BCDH
kinase in situ [16]. Stimulation of BCDH activity by
10 mM-leucine was nearly complete and corresponded to
complete dephosphorylation of the enzyme, as indicated
by the maximal incorporation of 32P into the enzyme
from leucine-treated tissues. The effects of insulin and
leucine were synergistic, i.e. together they stimulated
BCDH activity much more than would be expected if
their effects were additive. Insulin doubled BCDH activ-
ity over a wide range of leucine concentrations and
promoted dephosphorylation of the enzyme by an
amount that was proportional to the increase in the
enzyme activity. Therefore insulin and leucine appear to
activate BCDH by separate mechanisms. The effect of
insulin could be due to direct inhibition ofBCDH kinase
or to some process that facilitates the inhibition of
BCDH kinase by leucine. Alternatively, insulin might
stimulate BCDH phosphatase. Since the stimulatory
effects of leucine and insulin were still apparent after
BCDH activity was decreased as much as possible by
phosphorylating the enzyme, ligand-mediated inhibition
of BCDH kinase cannot fully account for the regulatory
effects of either leucine or insulin on BCDH activity.
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